{"id":64,"date":"2019-01-31T17:18:29","date_gmt":"2019-01-31T08:18:29","guid":{"rendered":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol-test\/en\/?page_id=64"},"modified":"2019-02-01T13:23:35","modified_gmt":"2019-02-01T04:23:35","slug":"achievements2012","status":"publish","type":"page","link":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/en\/achievements\/achievements2012\/","title":{"rendered":"2012"},"content":{"rendered":"

English-language papers(\u203bcorresponding author)<\/strong><\/h4>\n
    \n
  1. Takara K., Hiroto Hatakeyama H., Kibria G., Ohga N.,\u00a0Hida K.<\/u>, *Harashima H.: Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise foruse in drug-resistant cancer therapy,\u00a0J Controlled Release<\/em><\/strong>, 162(1), 225-232, 2012<\/li>\n
  2. Naznin Ara., Hyodo M., Ohga N.,\u00a0Hida K.<\/u>, Harashima H.: Development of a novel DNA aptamer ligand against primary cultured tumor endothelial cells,\u00a0PLoS ONE<\/em><\/strong>, 7(12), e50174, 2012<\/li>\n
  3. Osawa T., Ohga N., Hida Y., Kitayama K., Akiyama K., Onodera Y., Fujie M., Shinohara N., Nonomura K., Shindoh M. ,\u00a0*Hida K.<\/u>: Prostacyclin receptor in tumor endothelial cells promotes angiogenesis in an autocrine manner,\u00a0Cancer Sci<\/strong><\/em>, 103(6), 1038-1044, 2012<\/li>\n
  4. Kawamoto T., Ohga N., Akiyama K., Hirata N., Kitahara S, Maishi N., Osawa T., Yamamoto K., Kondoh M., Shindoh M., Hida Y.,\u00a0*Hida K.<\/u>: Tumor-derived microvesicles induce proangiogenic phenotype in endothelial cells via endocytosis,\u00a0PLoS ONE\u00a0<\/em><\/strong>7(3) :e34045, 2012<\/li>\n
  5. Yamamoto K., Ohga N., Hida Y., Maishi N., Kawamoto T., Kitayama K., Akiyama K., Osawa T., Kondoh M., Matsuda K., Onodera Y., Fujie M., Kaga K., Hirano S, Shinohara N., Shindoh M.,\u00a0*Hida K.<\/u>: Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells,\u00a0Br J Cancer<\/em><\/strong>, 106(6), 1214-1223, 2012<\/li>\n
  6. Maishi N., Ohga N., Hida Y.,\u3000 Akiyama K., Kitayama K., Osawa T., Onodera Y., Nonomura K., Shinohara N., Shindoh M.,\u00a0*<\/u>Hida K.<\/u>. : CXCR7 : A novel tumor endothelial marker in renal cell carcinoma,\u00a0Pathol Int,\u00a0<\/em><\/strong>62(5), 309-317, 2012<\/li>\n
  7. Ohga N.,Ishikawa S., Maishi N., Akiyama K., Hida Y.,\u3000Kawamoto T., Sadamoto Y., Osawa T.,Yamamoto K., Kondoh M., Ohmura H., Shinohara N., Nonomura K., Shindoh M.,\u00a0*Hida K<\/u>.\uff1aHeterogeneity of Tumor Endothelial Cells: Comparison between Tumor Endothelial Cells Isolated from Highly Metastatic and Low Metastatic Tumors,\u00a0Am J Pathol<\/em><\/strong>, 180(3), 1294-1307, 2012<\/li>\n
  8. Akiyama K., Ohga N., Hida Y., Kawamoto T., Sadamoto Y., Ishikawa S., Maishi N., Akino T., Kondoh M., Matsuda A., Inoue N., Shindoh M. and\u00a0*Hida K.<\/u>.: Tumor endothelial cells acquire drug resistance by MDR1 upregulation via VEGF signaling in tumor microenvironment,\u00a0Am J Pathol<\/em><\/strong>, 180(3), 1283-1293, 2012<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    English-language papers(\u203bcorresponding author) Takara K., Hiroto Hatakeyama H., Kibria G., Ohga N.,\u00a0Hida K., *Harashima H.: Size-controlled, dual-ligand modified liposomes that target the tumor vascul…\u7d9a\u304d\u3092\u8aad\u3080<\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"parent":19,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"publications.php","meta":{"footnotes":""},"class_list":["post-64","page","type-page","status-publish","hentry"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\t